What question did this study set out to answer?

This research aims to understand how translational control influences the progression of pancreatic ductal adenocarcinoma (PDAC).

eIF4G2-Dependent Translation Restrains Pancreatic Cancer Progression

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial investigates eIF4G2's role in pancreatic cancer progression, suggesting potential therapeutic targets.

This research aims to understand how translational control influences the progression of pancreatic ductal adenocarcinoma (PDAC).
Genome-wide CRISPR/Cas9 screen conducted in immunocompetent hosts to identify translational checkpoints.
Ribosome profiling used to evaluate mRNA translation and identify connections to tumor suppressors.
Expression levels of eIF4G2 assessed in human PDAC datasets to correlate with clinical outcomes.
Loss of eIF4G2 significantly accelerated tumor growth and metastasis in PDAC models.
eIF4G2 expression was lower in poorly differentiated lesions, correlating with adverse clinical features.
Reduced eIF4G2 activity linked with increased metastasis and poorer survival in human PDAC patients.

Powers et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial investigates eIF4G2's role in pancreatic cancer progression, suggesting potential therapeutic targets.

This research aims to understand how translational control influences the progression of pancreatic ductal adenocarcinoma (PDAC).
Genome-wide CRISPR/Cas9 screen conducted in immunocompetent hosts to identify translational checkpoints.
Ribosome profiling used to evaluate mRNA translation and identify connections to tumor suppressors.
Expression levels of eIF4G2 assessed in human PDAC datasets to correlate with clinical outcomes.
Loss of eIF4G2 significantly accelerated tumor growth and metastasis in PDAC models.
eIF4G2 expression was lower in poorly differentiated lesions, correlating with adverse clinical features.
Reduced eIF4G2 activity linked with increased metastasis and poorer survival in human PDAC patients.

Powers et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark